OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.3K citations · Full text

Medicine, Oncology, Pharmacology +13

A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment

Susanne J. Szabo, Sean Kim, Gina L. Costa et al. · Cell · 2000 · 3.5K citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation

Robert J. Johnston, Amanda C. Poholek, Daniel DiToro et al. · Science · 2009 · 1.6K citations

Life Sciences, Immunology, Molecular Biology +17

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

Daniela S. Thommen, Viktor H. Koelzer, Petra Herzig et al. · Nature Medicine · 2018 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +16

CD8 ⁺ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection

Robert Thimme, Stefan Wieland, Carola Steiger et al. · Journal of Virology · 2002 · 974 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17